Observation clinical registry study to evaluate safety and efficacy of 0.5% carboxymethylcellulose in dry eye disease patients

Post Marketing, Single Arm, Observational Clinical Registry to Evaluate Safety and Efficacy of 0.5% Carboxymethylcellulose Eye Solution in real-world population with dry eye disease patients.

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2020/10/028479

Enrollment

629

Registered

2020-10-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H00-H59- Diseases of the eye and adnexa

Interventions

Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who are able to give voluntary, written informed consent to participate in this clinical investigation and from whom consent has been obtained. 2. Patients having moderate to severe symptoms suggestive of dry eye wherein the study product would be prescribed by Investigator as part of standard of care. 3. Patients who have been prescribed study product by Investigator as part of standard of care (SOC) practice and consent has been provided by patient post prescription of study product on the same day.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1. Patients having any ocular diseases (corneal abrasion, ocular infection, foreign body trapping or ocular trauma), present or past, other than dry eye 2. History of ocular surgery. History or active signs of severe or serious ocular conditions such as inflammatory corneal ulcers, recurrent erosions, and uveitis at any time 3. Patients using contact lens or topic treatments other than tear substitutes 4. History or active signs of ocular trauma, ocular infection, or ocular inflammation within the last 3 months 5. History or active signs of ocular allergic disease or ocular herpes within the last year 6. Patients participating in any another clinical trial during study 7. Pregnant/lactating women during study period.

Design outcomes

Primary

Measure	Time frame
The primary objective of this study is to evaluate the safety and efficacy of 0.5% Carboxymethylcellulose Eye Drops in real world all comers population Timepoint: Baseline, Day 15 and Day 35	—

Secondary

Measure	Time frame
Not applicableTimepoint: Not applicable	—

Countries

India

Contacts

Public ContactRajdeep Patel

Consultant Ophthalmologist

sumit_rastogi_1977@yahoo.com9453294577

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026